Nike 12-Year, Lululemon 8-Year: July Turnaround Prospect
Two iconic brands face different paths to recovery. This deep-dive weighs Nike 12-Year and Lululemon 8-Year dynamics,...
Index values follow a defined daily schedule so investors know when to expect updates. This brief explains the publication times and how to use the data in your investing routine.
21,512 articlesTwo iconic brands face different paths to recovery. This deep-dive weighs Nike 12-Year and Lululemon 8-Year dynamics,...
Starboard Value’s effort at Dynatrace tests whether the observability software maker can turn around on its own or be...
Carl Icahn’s latest stake move in Icahn Enterprises drew attention from investors. This article breaks down what icah...
Investors have watched Peloton stumble from its pandemic-era peak to today’s volatile trading. This guide digs into w...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A new wave of history meets crypto in Cardsmiths' America250 trading cards. Some packs hide redemption codes for real...
Tom Cruise’s Digger teaser confuses viewers and even investors. This article breaks down what happened, why it matter...
Greg Abel, seen as Warren Buffett's successor, made a bold move by trimming UnitedHealth from Berkshire's portfolio. ...
Can a struggling retailer reinvent itself into a Berkshire Hathaway-style holding company? This article weighs the bl...
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Meta vs Alphabet in 2026 shapes a critical decision for many investors. This guide breaks down the core factors, offe...
Retailers are deploying in-store and online tactics that leverage human psychology to boost spending. Investors are e...